Page 2 - Foralumab News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Foralumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Foralumab Today - Breaking & Trending Today
Webinar to take place on Monday, June 5, 2023 at 12:30 PM ETNEW YORK, May 25, 2023) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes ....
NEW YORK, May 17, 2023) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that its Chief Medical ....
Application for $3M of non-dilutive funding for Phase 2a Alzheimer's trial will be submitted in Q2 2023Tiziana guided by FDA Type "B" meeting comments on its scheduled Q2 2023 intranasal foralumab Alzheimer's ....
CD3 antibody has emerged as an established and attractive target for Type 1 diabetes after the $2.9 billion acquisition of Provention Bio by SanofiMechanism of Action of Tiziana's first-in-class, only ....
Long COVID remains a high unmet need causing a myriad of complications for patients and costing the U.S. healthcare system an estimated $2.6 trillionThe role of activated microglia is well-established ....